棉铃虫雌性成虫脂肪体cDNA文库的构建

用异硫氰酸胍 酚 氯仿 步法从棉铃虫雌性成虫脂肪体中提取总RNA ,经过Oligo(dT)纤维柱分离出mRNA .以mRNA为模板 ,Oligo(dT)为引物 ,在逆转录酶催化下合成单链cDNA(sscDNA) .然后在E .coliDNA聚合酶Ⅰ与RNaseH共同作用下 ,进一步合成双链cDNA(dscDNA) .平末端dscDNA与EcoRI/NotI接头连接 ,插入λgt11表达载体 ,经体外包装后转染Y10 90 r 宿主菌 ,构建成棉铃虫脂肪体cDNA文库 .该文库的滴度为 3.5× 10 5pfu/mL ,重组率为 10 0 % ,该文库适合于筛选低丰度mRNA的cDNA克隆 .     

人Kai-1基因真核表达载体的构建及其体外表达

克隆人Kai-1基因,构建其真核表达载体,并在体外细胞系中进行表达验证。提取人正常肝细胞系HL7702的总RNA,通过RT-PCR其反转录为c DNA;以该c DNA为模板,通过PCR扩增出Kai-1基因的编码区,将该目的片段纯化后亚克隆入真核表达载体pc DNA3.1myc-his(-)中,利用菌落PCR及DNA测序分别对Kai-1基因编码区的大小及序列进行鉴定。将所构建的重组质粒通过脂质体瞬时转染Hela细胞,48 h后裂解细胞,利用Western blot检测有无目的蛋白的表达。测序证实所克隆的Kai-1编码区c DNA正确地插入pc DNA3.1myc-his(-)中,经Western blot检测证实其在Hela细胞中得到表达。成功克隆了人Kai-1 c DNA,构建了其真核表达载体,并在Hela细胞中得到有效表达,为进一步研究Kai-1的功能奠定了基础。     

牛肠激酶催化亚基cDNA的克隆及融合表达载体的构建

肠激酶(Enterokinase,EK)是目前生物制药领域纯化重组蛋白产品时用于切割融合蛋白的首选工具酶之一．为克隆表达牛肠激酶催化亚基(EKL)编码的基因,以期应用于融合蛋白的切割与纯化,从市售肉牛十二指肠组织中提取总RNA,以RT-PCR方法扩增其cDNA片段,将此片段克隆于pUCm-T载体中进行全序列分析．结果表明克隆的cDNA与GenBank上的序列相比完全一致．随后,将目的基因片段插入pET32a融合型表达载体中．经测序证实其重组DNA5’端多克隆位点与重组片段的接口处核苷酸顺序准确无误,所表达重组蛋白经SDS-PAGE分析,相对分子质量为50kD,表达量达38％,为进一步进行Enterokinase催化亚基蛋白表达及活性研究奠定了基础．     

忽地笑(Lycoris aurea)叶片cDNA文库的构建与分析

用表达型噬菌体载体ZAP构建了忽地笑叶片cDNA文库。文库宿主菌为E.coliXL1 BLUE,亚克隆空菌为E.coliXLOLR。初始文库的滴度为5.6×105pfu/mL,扩增文库的滴度为6.9×109pfu/mL,含插入片段的频率为96%,插入片段大小在0.5～2.5kb,文库质量良好。为进一步从基因组学和分子生物学方面研究忽地笑叶片发育及克隆相关全长基因奠定了基础。     

Infective viruses produced from full-length complementary DNA of swine vesicular disease viruses HK/70 strain

Swine vesicular disease (SVD) is a highly conta- gious viral disease of pigs. Symptoms are clinically indistinguishable from those caused by other vesiculardisease viruses, such as foot and mouth disease (FMD virus, vesicular stomatitis (VS) virus and ves…     

人类扭转蛋白A的基因克隆、表达与蛋白质纯化(I)——DYT1基因克隆与原核表达

通过基因工程方法,用大肠杆菌原核表达系统表达人扭转蛋白A.从该蛋白编码序列中设计引物,以人肝cDNA文库作模板扩增到编码该蛋白的基因片段.将所得片段与pMD l8-T载体连接,转化到JM l09大肠杆菌中,从转化平板上挑出菌落,用碱裂解法提取质粒,通过PCR和酶切分析,筛选到阳性克隆,测序结果与文献报道结果一致.提取质粒,用BamHI和XhoI酶切,回收目的片段,分别克隆到原核表达载体pET28a( )和pGEX-6P-1中,转化JM l09受体菌,从JM l09受体菌中提出质粒,再转化到BL21(DE3)菌中,筛选出阳性克隆,构建了人扭转蛋白A原核表达载体.IPTG诱导该工程菌,培养并离心收集.SDS-PAGE结果表明该蛋白在两种载体中均得到了高效表达.     

Nervous tissue proteoglycans

The structure, biosynthesis, localization, and possible functional roles of nervous tissue glycosaminoglycans and proteoglycans were last reviewed several years ago^70,74. Since that time, there has been an exponential increase in publications on the neurobiology of proteoglycans. This review will therefore focus on reports which have appeared in the period after 1988, and especially on those concerning the properties of individual characterized nervous tissue proteoglycans. Related areas such as the regulation of glycosaminoglycan biosynthesis and the roles of cell surface proteoglycans in adhesion and growth control are covered in other contributions to this special topic issue.     

Molecular pathology and pathobiology of osteoarthritic cartilage

The biochemical properties of articular cartilage rely on the biochemical composition and integrity of its extracellular matrix. This matrix consists mainly of a collagen network and the proteoglycan-rich ground substance. In osteoarthritis, ongoing cartilage matrix destruction takes place, leading to a progressive loss in joint function. Beside the degradation of molecular matrix components, destabilization of supramolecular structures such as the collagen network and changes in the expression profile of matrix molecules also take place. These processes, as well as the pattern of cellular reaction, explain the pathology of osteoarthritic cartilage degeneration. The loss of histochemical proteoglycan staining reflects the damage at the molecular level, whereas the supramolecular matrix destruction leads to fissuring and finally to the loss of the cartilage. Chondrocytes react by increasing matrix synthesis, proliferating, and changing their cellular phenotype. Gene expression mapping in situ and gene expression profiling allows characterization of the osteoarthritic cellular phenotype, a key determinant for understanding and manipulating the osteoarthritic disease process.